4BIO Capital

About

4BIO Capital is a London-based venture capital firm that specializes in investments in the advanced therapies sector. The firm focuses on supporting early-stage companies developing treatments for high unmet medical needs, aiming to make potentially curative therapies accessible to all patients.The company provides capital, strategic guidance, and industry expertise to accelerate the development and commercialization of transformative therapies. Its investment areas include cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome. The team at 4BIO Capital consists of leading scientists and experienced life science investors, giving them a strong understanding of successful investment opportunities in advanced therapies.4BIO Capital has made notable investments, including leading a $28.4 million Series A financing round for March Biosciences, a company focused on innovative cancer treatments. With a dedicated team and a clear mission, 4BIO Capital is committed to advancing healthcare and improving patient outcomes globally.

Benefits

• Capital investment for early-stage companies.
• Strategic guidance for development and commercialization.
• Industry expertise in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome.
• Access to a team of leading scientists and experienced life science investors.
• Notable investments in innovative healthcare companies like March Biosciences.

Eligibility Criteria

• Startups in the advanced therapies sector.
• Focus on treatments for high unmet medical needs.
• Early-stage companies with transformative therapies.
• Seeking capital, strategic guidance, and industry expertise.